Naltrexone shortage status
1 active shortage notice across 1 country.
Last updated 17 Sept 2026 · sourced from official medicines regulators
- Generic name (INN)
- Naltrexone
- Class
- Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Where Naltrexone is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| New Zealand | high | 1 | 20 Aug 2026 | — | Pharmac |
Why Naltrexone is in shortage
- supply-chain disruption — e.g. “Naltraccord brand naltrexone 50 mg tablets may run out before the new funded brand is available. A temporary alternative has been funded.” (New Zealand)
Frequently asked questions
Is Naltrexone currently in shortage?
Yes. As of the latest regulator updates, Naltrexone has 1 active shortage notice across 1 country (New Zealand). Status is refreshed daily from official regulatory sources.
Why is Naltrexone in shortage?
Regulators attribute the current Naltrexone shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Naltrexone shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Naltrexone status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.